Morningside Venture Investments Ltd, 10% Owner at Apellis Pharmaceuticals, Inc. (APLS), bought 250,000 shares at $40.00 ($10.0M) on 2021-11-18, disclosed to the SEC on 2021-11-18.
Open-market purchase of $10.0M APLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |